Seattle Children’s Hospital
Date of Award
Type 1 Diabetes, Prevent & Delay
Term of Grant
Development of antigen-specific eTreg therapy in T1D - Stage 3 Studies
Funds will support studies to develop an engineered targeted Treg cell therapy to treat type 1 diabetes.